- $10.48m
- -$19.58m
- $23.22m
- 52
- 99
- 62
- 83
Annual income statement for Heliogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.2 | 8.8 | 13.8 | 4.45 | 23.2 |
| Cost of Revenue | |||||
| Gross Profit | -0.217 | -0.135 | -0.009 | -2.75 | 15.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 7.72 | 52.8 | 174 | 140 | -6.4 |
| Operating Profit | -7.52 | -44 | -160 | -135 | 29.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -7.44 | -137 | -143 | -130 | 32.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.44 | -137 | -142 | -130 | 32.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.44 | -137 | -142 | -130 | 32.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.44 | -137 | -142 | -130 | 32.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.42 | -26.1 | -21.3 | -15.5 | -1.74 |
| Dividends per Share |